Symbols / STE Stock $208.10 -2.25% STERIS plc

Healthcare • Medical Devices • United States • NYQ
STE (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Mr. Daniel A. Carestio
Exch · Country NYQ · United States
Market Cap 20.31B
Enterprise Value 22.44B
Income 782.30M
Sales 5.94B
FCF (ttm) 837.29M
Book/sh 73.45
Cash/sh 4.50
Employees 17,937
Insider 10d —
IPO Jun 01, 1992
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 31.02%
P/E 26.21
Forward P/E 17.19
PEG 1.44
P/S 3.42
P/B 2.83
P/C —
EV/EBITDA 14.04
EV/Sales 3.78
Quick Ratio 1.34
Current Ratio 2.09
Debt/Eq 29.00
LT Debt/Eq —
EPS (ttm) 7.94
EPS next Y 12.11
EPS Growth 52.20%
Revenue Growth 7.30%
EPS Gr Q/Q 51.20%
Rev Gr Q/Q —
Earnings (next) 2026-08-05
Earnings (prior) 2026-05-11
ROA 6.65%
ROE 11.37%
ROIC —
Gross Margin 44.24%
Oper. Margin 20.04%
Profit Margin 13.18%
Shs Outstand 97.60M
Shs Float 97.19M
Insider Own 0.32%
Instit Own 100.63%
Short Float 2.11%
Short Ratio 2.09
Short Interest 1.81M
52W High 269.44
vs 52W High -22.77%
52W Low 195.14
vs 52W Low 6.64%
Beta 0.92
Impl. Vol. 37.36%
Rel Volume 0.74
Avg Volume 797.15K
Volume 588.86K
Target (mean) $256.86
Tgt Median $269.00
Tgt Low $225.00
Tgt High $280.00
# Analysts 7
Recom Buy
Prev Close $212.88
Price $208.10
Change -2.25%
About

STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services. It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting. In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment. It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals. The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015. STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$256.86
Mean price target
2. Current target
$208.10
Latest analyst target
3. DCF / Fair value
$154.41
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$208.10
Low
$225.00
High
$280.00
Mean
$256.86

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-05-13 main Keybanc Overweight → Overweight $269
2025-08-08 main Morgan Stanley Overweight → Overweight $295
2025-07-22 main Keybanc Overweight → Overweight $288
2025-07-15 up Morgan Stanley Equal-Weight → Overweight $276
2025-05-29 init Jefferies — → Hold $263
2025-05-19 main Morgan Stanley Equal-Weight → Equal-Weight $260
2025-05-16 main JMP Securities Market Outperform → Market Outperform $280
2025-05-15 reit Stephens & Co. Overweight → Overweight $250
2025-05-12 main Morgan Stanley Equal-Weight → Equal-Weight $240
2025-04-10 reit JMP Securities Market Outperform → Market Outperform $265
2025-04-07 reit Needham Hold → Hold —
2025-02-06 reit JMP Securities Market Outperform → Market Outperform $265
2025-02-06 reit Stephens & Co. Overweight → Overweight $240
2025-02-03 main Piper Sandler Overweight → Overweight $265
2024-11-18 reit JMP Securities Market Outperform → Market Outperform $265
2024-11-08 reit Needham — → Hold —
2024-11-07 reit Stephens & Co. Overweight → Overweight $260
2024-10-24 up Piper Sandler Neutral → Overweight $260
2024-08-08 reit Needham — → Hold —
2024-08-07 reit JMP Securities Market Outperform → Market Outperform $265
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-06-05 CARESTIO DANIEL A Chief Executive Officer — 4,428 $212.00 $946,799
2026-06-02 BREEDEN RICHARD C. Director — 1,481 $209.51 $310,284
2026-06-02 FRASER MARY CLARE Officer — 3,009 $0.00 $0
2026-06-02 MADSEN JULIA Officer — 2,316 $0.00 $0
2026-06-02 KOHLER KENNETH E Officer — 2,199 $0.00 $0
2026-06-02 MCGOWAN LINDSEY Officer — 1,155 $0.00 $0
2026-06-02 ZANGERLE JOHN ADAM General Counsel — 4,359 $0.00 $0
2026-06-02 CARESTIO DANIEL A Chief Executive Officer — 23,736 $0.00 $0
2026-06-02 BURTON KAREN L Chief Financial Officer — 5,325 $0.00 $0
2026-06-02 TAMARO RENATO Officer and Treasurer — 750 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2026-03-31 2025-03-31 2024-03-31 2023-03-31
Total Revenue
5,935.90
+8.73%
5,459.50
+6.24%
5,138.70
+13.28%
4,536.27
Operating Revenue
5,935.90
+8.73%
5,459.50
+6.24%
5,138.70
+13.28%
4,536.27
Cost Of Revenue
3,309.40
+8.26%
3,056.80
+4.67%
2,920.50
+14.28%
2,555.54
Reconciled Cost Of Revenue
3,309.40
+8.26%
3,056.80
+4.67%
2,920.50
+14.28%
2,555.54
Gross Profit
2,626.50
+9.31%
2,402.80
+8.32%
2,218.20
+11.99%
1,980.73
Operating Expense
1,520.60
+5.46%
1,441.90
+6.33%
1,356.00
+14.03%
1,189.14
Research And Development
112.90
+4.93%
107.60
+3.76%
103.70
+5.30%
98.48
Selling General And Administration
1,407.70
+5.50%
1,334.30
+6.55%
1,252.30
+14.82%
1,090.66
Total Expenses
4,830.00
+7.36%
4,498.70
+5.20%
4,276.50
+14.20%
3,744.68
Operating Income
1,105.90
+15.09%
960.90
+11.45%
862.20
+8.92%
791.59
Total Operating Income As Reported
1,101.80
+27.14%
866.60
+3.65%
836.10
+5.69%
791.10
EBITDA
1,594.50
+17.35%
1,358.70
-3.80%
1,412.40
+5.09%
1,344.00
Normalized EBITDA
1,598.60
+10.03%
1,452.90
+1.01%
1,438.40
+6.99%
1,344.48
Reconciled Depreciation
486.50
+2.16%
476.20
-15.75%
565.20
+2.23%
552.90
EBIT
1,108.00
+25.55%
882.50
+4.17%
847.20
+7.09%
791.10
Total Unusual Items
-4.10
+95.65%
-94.20
-262.31%
-26.00
-5260.82%
-0.48
Total Unusual Items Excluding Goodwill
-4.10
+95.65%
-94.20
-262.31%
-26.00
-5260.82%
-0.48
Special Income Charges
-4.10
+95.65%
-94.20
-262.31%
-26.00
-5260.82%
-0.48
Other Special Charges
—
48.20
—
—
Impairment Of Capital Assets
—
—
—
490.56
Restructuring And Mergern Acquisition
4.10
-91.09%
46.00
+76.92%
26.00
+5260.82%
0.48
Net Income
782.30
+27.27%
614.70
+62.49%
378.30
+253.45%
107.03
Pretax Income
1,047.30
+31.54%
796.20
+13.29%
702.80
+3.31%
680.27
Net Non Operating Interest Income Expense
-50.90
+34.66%
-77.90
+41.60%
-133.40
-20.36%
-110.83
Interest Expense Non Operating
60.70
-29.66%
86.30
-40.24%
144.40
+30.28%
110.83
Net Interest Income
-50.90
+34.66%
-77.90
+41.60%
-133.40
-20.36%
-110.83
Interest Expense
60.70
-29.66%
86.30
-40.24%
144.40
+30.28%
110.83
Interest Income Non Operating
9.80
+16.67%
8.40
-23.64%
11.00
—
Interest Income
9.80
+16.67%
8.40
-23.64%
11.00
—
Other Income Expense
-7.60
+91.24%
-86.80
-233.85%
-26.00
-5260.82%
-0.48
Other Non Operating Income Expenses
-3.50
-147.30%
7.40
—
—
Gain On Sale Of Business
—
7.42
0.00
0.00
Tax Provision
262.20
+41.96%
184.70
+23.55%
149.50
+20.50%
124.07
Tax Rate For Calcs
0.00
+7.92%
0.00
+8.91%
0.00
+17.03%
0.00
Tax Effect Of Unusual Items
-1.03
+95.30%
-21.85
-294.59%
-5.54
-6173.93%
-0.09
Net Income Including Noncontrolling Interests
785.10
+27.43%
616.10
+62.09%
380.10
+259.22%
105.81
Net Income From Continuing Operation Net Minority Interest
782.30
+28.20%
610.20
+10.64%
551.50
-1.06%
557.41
Net Income From Continuing And Discontinued Operation
782.30
+27.27%
614.70
+62.49%
378.30
+253.45%
107.03
Net Income Continuous Operations
785.10
+28.37%
611.60
+10.54%
553.30
-0.52%
556.20
Net Income Discontinuous Operations
0.00
-100.00%
4.50
+102.60%
-173.20
+61.54%
-450.38
Minority Interests
-2.80
-100.00%
-1.40
+22.22%
-1.80
-247.90%
1.22
Normalized Income
785.37
+15.06%
682.55
+19.33%
571.96
+2.54%
557.81
Net Income Common Stockholders
782.30
+27.29%
614.60
+62.51%
378.20
+253.36%
107.03
Diluted EPS
7.93
+27.90%
6.20
+62.73%
3.81
+256.07%
1.07
Basic EPS
7.97
+27.72%
6.24
+62.92%
3.83
+257.94%
1.07
Basic Average Shares
98.20
-0.38%
98.58
-0.21%
98.79
-0.92%
99.71
Diluted Average Shares
98.70
-0.37%
99.07
-0.29%
99.36
-0.88%
100.25
Diluted NI Availto Com Stockholders
782.30
+27.29%
614.60
+62.51%
378.20
+253.36%
107.03
Line Item Trend 2026-03-31 2025-03-31 2024-03-31 2023-03-31
Total Assets
10,737.20
+5.82%
10,146.80
-8.29%
11,063.70
+2.23%
10,821.84
Current Assets
2,394.60
+19.68%
2,000.80
-30.26%
2,869.12
+42.64%
2,011.44
Cash Cash Equivalents And Short Term Investments
439.60
+156.03%
171.70
-17.06%
207.02
-0.64%
208.36
Cash And Cash Equivalents
439.60
+156.03%
171.70
-17.06%
207.02
-0.64%
208.36
Receivables
1,092.80
+4.67%
1,044.00
+3.54%
1,008.32
+16.57%
864.99
Accounts Receivable
1,092.80
+4.67%
1,044.00
+3.54%
1,008.32
+16.57%
864.99
Gross Accounts Receivable
1,120.10
+4.84%
1,068.40
+3.60%
1,031.30
+16.63%
884.27
Allowance For Doubtful Accounts Receivable
-27.30
-11.89%
-24.40
-6.16%
-22.98
-19.19%
-19.28
Inventory
631.80
+8.69%
581.30
-13.82%
674.53
+11.60%
604.41
Raw Materials
225.40
+5.77%
213.10
-13.35%
245.94
+11.57%
220.43
Work In Process
90.70
+9.15%
83.10
-15.47%
98.30
+4.61%
93.97
Finished Goods
355.20
+6.06%
334.90
-10.50%
374.18
+14.92%
325.61
Prepaid Assets
—
—
—
179.28
Assets Held For Sale Current
—
0.00
-100.00%
804.90
+410.79%
157.58
Other Current Assets
230.40
+13.05%
203.80
+16.89%
174.35
-1.00%
176.11
Total Non Current Assets
8,342.70
+2.42%
8,145.90
-0.59%
8,194.57
-6.99%
8,810.40
Net PPE
2,316.50
+9.64%
2,112.90
+9.00%
1,938.38
+7.73%
1,799.33
Gross PPE
4,261.10
+10.85%
3,844.00
+9.44%
3,512.33
+9.30%
3,213.43
Accumulated Depreciation
-1,944.60
-12.33%
-1,731.10
-9.98%
-1,573.95
-11.30%
-1,414.10
Properties
0.00
0.00
0.00
0.00
Land And Improvements
112.30
+5.84%
106.10
+17.71%
90.13
+15.92%
77.76
Buildings And Improvements
903.60
+8.59%
832.10
+14.85%
724.49
+10.09%
658.11
Machinery Furniture Equipment
1,750.60
+17.69%
1,487.50
+11.69%
1,331.75
+10.90%
1,200.88
Construction In Progress
509.50
-0.51%
512.10
+2.40%
500.11
+5.91%
472.21
Other Properties
985.10
+8.71%
906.20
+4.66%
865.84
+7.63%
804.47
Goodwill And Other Intangible Assets
5,814.80
-2.27%
5,950.00
-3.88%
6,189.99
+3.93%
5,955.92
Goodwill
4,194.80
+2.42%
4,095.70
+0.61%
4,070.71
+4.94%
3,879.22
Other Intangible Assets
1,620.00
-12.64%
1,854.30
-12.50%
2,119.28
+2.05%
2,076.70
Other Non Current Assets
211.40
+154.70%
83.00
+25.38%
66.20
-93.73%
1,055.15
Total Liabilities Net Minority Interest
3,540.00
+0.25%
3,531.00
-25.64%
4,748.35
+0.29%
4,734.67
Current Liabilities
1,145.00
+12.01%
1,022.20
+9.78%
931.13
+8.04%
861.84
Payables And Accrued Expenses
423.60
+18.16%
358.50
+10.26%
325.14
-8.25%
354.36
Payables
367.40
+21.53%
302.30
+13.92%
265.36
-12.89%
304.64
Accounts Payable
338.80
+20.66%
280.80
+11.55%
251.72
-4.71%
264.17
Current Accrued Expenses
56.20
+0.00%
56.20
-5.98%
59.77
+20.23%
49.72
Employee Benefits
10.00
+6.38%
9.40
+2.10%
9.21
-8.83%
10.10
Pensionand Other Post Retirement Benefit Plans Current
221.10
+14.74%
192.70
+16.91%
164.83
+39.14%
118.46
Total Tax Payable
28.60
+33.02%
21.50
+57.62%
13.64
-66.30%
40.48
Income Tax Payable
28.60
+33.02%
21.50
+57.62%
13.64
-66.30%
40.48
Current Debt And Capital Lease Obligation
154.70
-2.83%
159.20
+35.86%
117.18
+30.10%
90.06
Current Debt
118.90
-4.88%
125.00
+45.45%
85.94
+43.23%
60.00
Other Current Borrowings
118.90
-4.88%
125.00
+45.45%
85.94
+43.23%
60.00
Current Capital Lease Obligation
35.80
+4.68%
34.20
+9.48%
31.24
+3.90%
30.07
Current Deferred Liabilities
59.10
+2.78%
57.50
-18.39%
70.46
-17.81%
85.73
Current Deferred Revenue
59.10
+2.78%
57.50
-18.39%
70.46
-17.81%
85.73
Other Current Liabilities
271.50
+13.79%
238.60
-0.46%
239.71
+19.04%
201.36
Total Non Current Liabilities Net Minority Interest
2,395.00
-4.54%
2,508.80
-34.28%
3,817.22
-1.44%
3,872.82
Liabilities Heldfor Sale Non Current
—
—
0.00
-100.00%
20.94
Long Term Debt And Capital Lease Obligation
1,932.50
-5.42%
2,043.30
-37.44%
3,265.99
+3.41%
3,158.21
Long Term Debt
1,812.90
-5.51%
1,918.70
-38.51%
3,120.16
+3.36%
3,018.66
Long Term Capital Lease Obligation
119.60
-4.01%
124.60
-14.56%
145.83
+4.49%
139.56
Long Term Provisions
39.50
+4.50%
37.80
+8.64%
34.79
+0.10%
34.76
Non Current Pension And Other Postretirement Benefit Plans
8.40
+3.70%
8.10
+2.71%
7.89
-11.85%
8.95
Tradeand Other Payables Non Current
0.30
-84.21%
1.90
-70.81%
6.51
-35.45%
10.08
Non Current Deferred Liabilities
390.70
-3.22%
403.70
-15.84%
479.69
-22.32%
617.54
Non Current Deferred Taxes Liabilities
390.70
-3.22%
403.70
-15.84%
479.69
-22.32%
617.54
Other Non Current Liabilities
22.00
+73.23%
12.70
-39.63%
21.04
-0.75%
21.20
Stockholders Equity
7,183.60
+8.79%
6,603.40
+4.78%
6,302.16
+3.70%
6,077.20
Common Stock Equity
7,183.60
+8.79%
6,603.40
+4.78%
6,302.16
+3.70%
6,077.20
Capital Stock
4,280.90
-3.16%
4,420.40
-2.70%
4,543.18
+1.27%
4,486.38
Common Stock
4,280.90
-3.16%
4,420.40
-2.70%
4,543.18
+1.27%
4,486.38
Share Issued
97.80
-0.51%
98.30
-0.59%
98.88
+0.26%
98.63
Ordinary Shares Number
97.80
-0.51%
98.30
-0.59%
98.88
+0.26%
98.63
Retained Earnings
3,015.90
+21.84%
2,475.30
+18.57%
2,087.64
+9.21%
1,911.53
Gains Losses Not Affecting Retained Earnings
-113.10
+61.31%
-292.30
+11.06%
-328.66
-2.48%
-320.71
Minority Interest
13.60
+9.68%
12.40
-5.93%
13.18
+32.16%
9.97
Other Equity Adjustments
-113.10
+61.31%
-292.30
+11.06%
-328.66
-2.48%
-320.71
Total Equity Gross Minority Interest
7,197.20
+8.79%
6,615.80
+4.76%
6,315.35
+3.75%
6,087.17
Total Capitalization
8,996.50
+5.57%
8,522.10
-9.55%
9,422.33
+3.59%
9,095.85
Working Capital
1,249.60
+27.69%
978.60
-49.50%
1,938.00
+68.58%
1,149.60
Invested Capital
9,115.40
+5.42%
8,647.10
-9.06%
9,508.26
+3.85%
9,155.85
Total Debt
2,087.20
-5.23%
2,202.50
-34.90%
3,383.17
+4.15%
3,248.28
Net Debt
1,492.20
-20.29%
1,872.00
-37.58%
2,999.08
+4.49%
2,870.30
Capital Lease Obligations
155.40
-2.14%
158.80
-10.32%
177.07
+4.39%
169.62
Net Tangible Assets
1,368.80
+109.49%
653.40
+482.51%
112.17
-7.51%
121.28
Tangible Book Value
1,368.80
+109.49%
653.40
+482.51%
112.17
-7.51%
121.28
Current Provisions
15.00
-4.46%
15.70
+13.66%
13.81
+16.39%
11.87
Interest Payable
6.20
-20.51%
7.80
-29.79%
11.11
+20.19%
9.24
Inventories Adjustments Allowances
-39.40
+20.88%
-49.80
-13.46%
-43.89
-23.29%
-35.60
Other Equity Interest
-0.10
—
—
—
Other Inventories
-0.10
—
—
—
Line Item Trend 2026-03-31 2025-03-31 2024-03-31 2023-03-31
Operating Cash Flow
1,341.40
+16.84%
1,148.10
+17.96%
973.30
+28.58%
756.95
Cash Flow From Continuing Operating Activities
1,341.20
+16.82%
1,148.10
+18.00%
973.00
+28.54%
756.95
Net Income From Continuing Operations
785.10
+27.43%
616.10
+62.09%
380.10
+259.22%
105.81
Depreciation Amortization Depletion
486.50
+2.16%
476.20
-15.75%
565.20
+2.23%
552.90
Other Non Cash Items
-5.40
-45.95%
-3.70
-101.65%
223.80
+1381.13%
-17.47
Stock Based Compensation
61.70
+7.49%
57.40
+1.59%
56.50
+45.05%
38.95
Asset Impairment Charge
—
0.00
0.00
-100.00%
490.56
Deferred Tax
-16.90
+77.91%
-76.50
+41.78%
-131.40
+29.32%
-185.91
Deferred Income Tax
-16.90
+77.91%
-76.50
+41.78%
-131.40
+29.32%
-185.91
Operating Gains Losses
3.30
-72.73%
12.10
-52.17%
25.30
+14.35%
22.13
Gain Loss On Investment Securities
—
—
-0.55
—
Gain Loss On Sale Of PPE
3.60
-36.84%
5.70
-77.20%
25.00
+12.65%
22.19
Change In Working Capital
27.10
-59.25%
66.50
+145.49%
-146.20
+41.53%
-250.02
Change In Receivables
-25.10
+12.85%
-28.80
+77.52%
-128.10
+3.90%
-133.30
Changes In Account Receivables
-25.10
+12.85%
-28.80
+77.52%
-128.10
+3.90%
-133.30
Change In Inventory
-24.00
-132.83%
73.10
+294.93%
-37.50
+69.74%
-123.92
Change In Payables And Accrued Expense
98.90
+36.41%
72.50
+245.24%
21.00
-32.88%
31.29
Change In Accrued Expense
47.80
+22.88%
38.90
-2.75%
40.00
+281.37%
-22.05
Change In Payable
51.10
+52.08%
33.60
+276.84%
-19.00
-135.62%
53.34
Change In Account Payable
51.10
+52.08%
33.60
+276.84%
-19.00
-135.62%
53.34
Change In Other Current Assets
-22.70
+54.87%
-50.30
-3043.75%
-1.60
+93.36%
-24.09
Investing Cash Flow
-512.50
-231.82%
388.80
+143.81%
-887.40
-131.50%
-383.33
Cash Flow From Continuing Investing Activities
-512.60
-231.84%
388.80
+143.82%
-887.30
-131.47%
-383.33
Net PPE Purchase And Sale
-358.50
+0.67%
-360.90
-2.27%
-352.90
-1.59%
-347.38
Purchase Of PPE
-369.00
+0.30%
-370.10
-2.72%
-360.30
+0.46%
-361.97
Sale Of PPE
10.50
+14.13%
9.20
+24.32%
7.40
-49.27%
14.59
Capital Expenditure
-369.00
+0.30%
-370.10
-2.72%
-360.30
+0.46%
-361.97
Net Investment Purchase And Sale
-134.00
-1140.74%
-10.80
-550.00%
2.40
0.00
Purchase Of Investment
-134.00
-1140.74%
-10.80
-620.00%
-1.50
0.00
Sale Of Investment
0.00
0.00
-100.00%
3.90
0.00
Net Business Purchase And Sale
-20.10
-102.64%
760.50
+241.67%
-536.80
-1393.27%
-35.95
Purchase Of Business
-20.10
+62.85%
-54.10
+90.10%
-546.30
-1183.24%
-42.57
Gain Loss On Sale Of Business
-0.30
-104.69%
6.40
+2033.33%
0.30
+547.76%
-0.07
Net Other Investing Changes
0.10
—
-0.10
—
Financing Cash Flow
-568.20
+63.86%
-1,572.40
-1745.54%
-85.20
+82.92%
-498.72
Cash Flow From Continuing Financing Activities
-568.20
+63.86%
-1,572.40
-1745.54%
-85.20
+82.92%
-498.72
Net Issuance Payments Of Debt
-122.00
+89.52%
-1,164.40
-1058.35%
121.50
+2054.00%
-6.22
Issuance Of Debt
3.00
—
181.50
-24.89%
241.66
Repayment Of Debt
-125.00
+89.26%
-1,164.40
-1840.67%
-60.00
+75.79%
-247.88
Long Term Debt Issuance
3.00
—
181.50
-24.89%
241.66
Long Term Debt Payments
-125.00
+89.26%
-1,164.40
-1840.67%
-60.00
+75.79%
-247.88
Net Long Term Debt Issuance
-122.00
+89.52%
-1,164.40
-1058.35%
121.50
+2054.00%
-6.22
Short Term Debt Payments
—
—
—
—
Net Short Term Debt Issuance
—
—
181.49
-24.90%
241.66
Net Common Stock Issuance
-235.50
-11.45%
-211.30
-1690.68%
-11.80
+96.18%
-308.56
Common Stock Payments
-235.50
-11.45%
-211.30
-1690.68%
-11.80
+96.18%
-308.56
Common Stock Dividend Paid
-241.80
-9.96%
-219.90
-9.62%
-200.60
-9.32%
-183.50
Cash Dividends Paid
-241.80
-9.96%
-219.90
-9.62%
-200.60
-9.32%
-183.50
Repurchase Of Capital Stock
-235.50
-11.45%
-211.30
-1690.68%
-11.80
+96.18%
-308.56
Proceeds From Stock Option Exercised
32.90
+29.02%
25.50
+142.86%
10.50
+474.40%
1.83
Net Other Financing Charges
-1.80
+21.74%
-2.30
+52.08%
-4.80
-111.92%
-2.27
Changes In Cash
260.70
+834.37%
-35.50
-5171.43%
0.70
+100.56%
-125.10
Effect Of Exchange Rate Changes
7.20
+3500.00%
0.20
+109.52%
-2.10
+85.87%
-14.86
Beginning Cash Position
171.70
-17.05%
207.00
-0.67%
208.40
-40.17%
348.32
End Cash Position
439.60
+156.03%
171.70
-17.05%
207.00
-0.65%
208.36
Free Cash Flow
972.40
+24.99%
778.00
+26.92%
613.00
+55.20%
394.98
Interest Paid Supplemental Data
—
89.40
-37.12%
142.17
+31.07%
108.47
Income Tax Paid Supplemental Data
—
273.61
+0.86%
271.27
+6.52%
254.66
Sale Of Business
0.00
-100.00%
814.60
+8474.74%
9.50
+43.42%
6.62
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category